Bull
$8.64
Precio del escenario
$2.600
+0.104 (+4.00%)Al cierre
National CineMedia, Inc. operates the cinema advertising platform in the United States. Its cinema advertising platform consists of more than 17,000 screens in over 1,300 theaters in 184 Designated Market Areas. It presents multiple formats of The Noovie Show and Cinelife Show depending on the theater circuit in which it runs, including Post-Showtime advertising inventory after the advertised showtime. It also sells advertising on its LEN, a series of strategically placed screens located in movie theater lobbies, as well as other forms of advertising, promotions and experiences in theater lobbies. In addition, it sells digital advertising through the NCMx suite of products and through its Noovie digital properties. NCMx is a data, insights and analytics platform. The Noovie Show with Post-Showtime Inventory format is typically comprised of three segments that are approximately four to ten minutes in length and shown prior to showtime, as well as two additional advertising segments.
National Cinemedia Inc is currently trading at $2.60, which is significantly below the analyst price target of $5, suggesting potential upside. However, the company has a forward P/E of 74.63, indicating high valuation concerns. The RSI of 40.17 suggests that the stock is nearing oversold territory, which could lead to a rebound. The main risk is the recent hedge fund selling, which has increased by 10,438.36% over the last quarter, indicating a lack of confidence among institutional investors.
Wedbush
$5
2026-08-12
Wedbush
2026-08-12
Precio objetivo
$5
B. Riley
$4
2026-01-22
B. Riley
2026-01-22
Precio objetivo
$4
Benchmark
$6
2026-01-07
Benchmark
2026-01-07
Precio objetivo
$6
Benchmark
$7
2025-06-25
Benchmark
2025-06-25
Precio objetivo
$7
B. Riley
$6
2025-05-16
B. Riley
2025-05-16
Precio objetivo
$6
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Advertising Stocks Show Strength, Led by National CineMedia

Cinema Advertising Boosts Kidney Donation Efforts

National CineMedia Declares Quarterly Dividend of $0.03 per Share

National CineMedia Q1 2026 Earnings Call Insights

National CineMedia to Announce Q1 Earnings on May 12
National CineMedia, Inc. operates the cinema advertising platform in the United States. Its cinema advertising platform consists of more than 17,000 screens in over 1,300 theaters in 184 Designated Market Areas. It presents multiple formats of The Noovie Show and Cinelife Show depending on the theater circuit in which it runs, including Post-Showtime advertising inventory after the advertised showtime. It also sells advertising on its LEN, a series of strategically placed screens located in movie theater lobbies, as well as other forms of advertising, promotions and experiences in theater lobbies. In addition, it sells digital advertising through the NCMx suite of products and through its Noovie digital properties. NCMx is a data, insights and analytics platform. The Noovie Show with Post-Showtime Inventory format is typically comprised of three segments that are approximately four to ten minutes in length and shown prior to showtime, as well as two additional advertising segments. It operates in the Consumer Cyclicals sector (SERVICES-ADVERTISING industry).
National Cinemedia Inc is currently trading at $2.60, which is significantly below the analyst price target of $5, suggesting potential upside. However, the company has a forward P/E of 74.63, indicating high valuation concerns. The RSI of 40.17 suggests that the stock is nearing oversold territory, which could lead to a rebound. The main risk is the recent hedge fund selling, which has increased by 10,438.36% over the last quarter, indicating a lack of confidence among institutional investors.
7 analysts cover NCMI: 2 rate it Buy, 4 Hold and 1 Sell. The average price target is 5.83.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.